All News

Tezepelumab Achieves Dual Benefit in Adults with Severe Asthma: Daily Dose
December 17, 2025

Your daily dose of the clinical news you may have missed.

GLP-1 RAs Carry Higher Risk of Serious GI Side Effects Than SGLT-2 Inhibitors: Daily Dose
December 17, 2025

Your daily dose of the clinical news you may have missed.

Epicutaneous Immunotherapy Patch Reduces Peanut Reactivity in Children, Phase 3 Data Show
December 17, 2025

The VITESSE trial met its primary endpoint, with the VIASKIN Peanut patch improving desensitization versus placebo in peanut-allergic children aged 4 to 7 years.

Colorectal Cancer Screening in 2025: What Changed, and What Didn't, with Mark Fendrick, MD
December 17, 2025

Physician researcher Fendrick offers an expert perspective on why removing cost barriers matters, and why navigation and patient realities still determine whether CRC screening succeeds.

After ACIP Debate, CDC Modifies Longstanding Hepatitis B Birth Dose Recommendation
December 17, 2025

CDC officials say the shift reflects evidence review and informed consent, as public health groups warn of potential downstream effects.

Rezpegaldesleukin Demonstrates Proof of Concept in Phase 2b Trial for Severe Alopecia Areata
December 17, 2025

Phase 2b REZOLVE-AA trial results show rezpegaldesleukin reduced SALT scores versus placebo in severe alopecia areata, supporting Phase 3 development.

FDA Approves GSK's Depimokimab for Severe Asthma with Th2 Inflammation, First Ultra-Long Acting Biologic
December 17, 2025

Approval of the novel long-acting mAb was based on the phase 3 SWIFT-1 and SWIFT-2 trials, which showed steep reductions in annualized asthma exacerbations requiring ED or inpatient care.

Hidradenitis Suppurativa Essentials for Primary Care: When to Suspect, Initial Therapy, and When to Refer
December 17, 2025

This is a topline look for primary care on when to suspect hidradenitis suppurativa, how to stage severity, and when to escalate treatment or refer to dermatology.

New CRC Screening Guidelines Lead to Near 10-Fold Uptake for Adults Aged 45 to 49 Years: Daily Dose
December 17, 2025

Your daily dose of the clinical news you may have missed.

With Colonoscopy Capacity Limited, We Need More Momentum Behind Noninvasive Home-Based Tests, Says Mark Fendrick, MD
December 16, 2025

Fendrick considers the current state of colorectal cancer screening in the US, emphasizing limited colonoscopy capacity and patient preferences for at-home tests.